Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pang

Showing results (791-800 of 824) with videos related to

Pageof 83
Sort By:
Journal of Cardiology|October 15, 2020
Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rateÒscar Miró, María Pilar López-Díez, Xavier Rossello, et al.
The New England Journal of Medicine|April 15, 2014
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infectionNezam Afdhal, K Rajender Reddy, David R Nelson, et al.
The New England Journal of Medicine|April 12, 2014
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosisKris V Kowdley, Stuart C Gordon, K Rajender Reddy, et al.
Open Forum Infectious Diseases|August 14, 2023
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical TrialAdrienne E Shapiro, Elias Sarkis, Jude Acloque, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 11, 2024
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF studyJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
ESC Heart Failure|February 12, 2025
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF studyAlbertino Damasceno, Hadiza Saidu, Gad Cotter, et al.
European Journal of Heart Failure|September 20, 2023
Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trialOvidiu Chioncel, Beth Davison, Marianna Adamo, et al.
European Journal of Heart Failure|May 16, 2023
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trialKamilė Čerlinskaitė-Bajorė, Carolyn S P Lam, Karen Sliwa, et al.
Circulation. Heart Failure|March 6, 2024
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF TrialJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
JACC. Heart Failure|May 13, 2024
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of RiskAndrew P Ambrosy, Alex J Chang, Beth Davison, et al.
Pageof 83

Showing results (791-800 of 824) with videos related to

Sort By:
Pageof 83
Journal of Cardiology|October 15, 2020
Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rateÒscar Miró, María Pilar López-Díez, Xavier Rossello, et al.
The New England Journal of Medicine|April 15, 2014
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infectionNezam Afdhal, K Rajender Reddy, David R Nelson, et al.
The New England Journal of Medicine|April 12, 2014
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosisKris V Kowdley, Stuart C Gordon, K Rajender Reddy, et al.
Open Forum Infectious Diseases|August 14, 2023
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical TrialAdrienne E Shapiro, Elias Sarkis, Jude Acloque, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 11, 2024
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF studyJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
ESC Heart Failure|February 12, 2025
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF studyAlbertino Damasceno, Hadiza Saidu, Gad Cotter, et al.
European Journal of Heart Failure|September 20, 2023
Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trialOvidiu Chioncel, Beth Davison, Marianna Adamo, et al.
European Journal of Heart Failure|May 16, 2023
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trialKamilė Čerlinskaitė-Bajorė, Carolyn S P Lam, Karen Sliwa, et al.
Circulation. Heart Failure|March 6, 2024
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF TrialJelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, et al.
JACC. Heart Failure|May 13, 2024
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of RiskAndrew P Ambrosy, Alex J Chang, Beth Davison, et al.
Pageof 83